Skip to main content
Equibles

DMG · DR. MIELE COSMED GROUP SPÓŁKA AKCYJNA · Financials

Use DMG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DMG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
2.0700 PLN +0.0500 (+2.48%) At close · Oct 2
Rebalance outlook locked
Market Cap
188.71M PLN
Shares
85.78M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
504.21M +3.2%
FY2025 Revenue FY2019–FY2025
Net Income
19.69M -45.3%
FY2025 Net Income FY2019–FY2025
Gross Margin
5.75% -3.7pp
FY2025 Gross Margin FY2020–FY2025
Operating Margin
6.06% -3.9pp
FY2025 Operating Margin FY2019–FY2025
Operating Cash Flow
39.14M -14.4%
FY2025 Operating Cash Flow FY2019–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
PLN 504.21M 488.35M 444.48M 396.57M 351.87M 364.81M 309.86M
PLN 29M 46.25M 33.22M 2.03M 13.69M 32.12M —
PLN 14.44M 12.56M 11.96M 11.34M 10.65M 10.92M 10.82M
PLN 30.54M 48.62M 33.05M 1.31M 15.05M 31.94M 8.6M
PLN 5.7M 5.63M 6.03M 3.81M 2.09M 2.66M 3.89M
PLN 24.99M 43.36M 27.2M -2.1M 13.26M 31.3M 4.93M
PLN 5.3M 7.37M 4.98M 170K 1.66M 2.68M 1.58M
PLN 19.69M 35.99M 22.22M -2.27M 11.6M 28.63M 3.35M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: 8.21M in buybacks, 19.98M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Reported debt balances

Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.

Reported balanceAs ofAmountSource
Current borrowings, including current portion of noncurrent borrowings 2025-12-31 PLN 49,087,000 ESEF Annual Report filed 2026-04-16
Current lease liabilities 2025-12-31 PLN 3,996,000 ESEF Annual Report filed 2026-04-16
Noncurrent lease liabilities 2025-12-31 PLN 10,012,000 ESEF Annual Report filed 2026-04-16
Noncurrent long-term borrowings 2025-12-31 PLN 59,000 ESEF Annual Report filed 2026-04-16
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.